Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Glioma
National Cancer Institute (NCI)
P2
CC
(47)
Panitumumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
pds01adc
Cholangiocarcinoma
National Cancer Institute (NCI)
P2
CC
(47)
pds01adc
Colorectal Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
pds01adc
Intrahepatic Cholangiocarcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Pertuzumab
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Pertuzumab
Glioma
National Cancer Institute (NCI)
P2
CC
(47)
Plerixafor
Plasma Cell Leukemia
National Cancer Institute (NCI)
P2
CC
(47)
Recombinant Human Granulocyte Colony-Stimulating Factor
Plasma Cell Leukemia
National Cancer Institute (NCI)
P2
CC
(47)
Recombinant Human Hyaluronidase
Plasma Cell Leukemia
National Cancer Institute (NCI)
P2
CC
(47)
Relatlimab
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Relatlimab
Glioma
National Cancer Institute (NCI)
P2
CC
(47)
Sapanisertib
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Sapanisertib
Glioma
National Cancer Institute (NCI)
P2
CC
(47)
Selumetinib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
Sotorasib
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
Taselisib
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CC
(47)
Taselisib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Taselisib
Prostate Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Taselisib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
Tcr Transduced T-Cells
Neuroendocrine Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
Telaglenastat
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P2
CC
(47)
Tpst-1495
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Trastuzumab
Glioma
National Cancer Institute (NCI)
P2
CC
(47)
Trastuzumab Emtansine
Colorectal Carcinoma
National Cancer Institute (NCI)
P2
CC
(47)
Showing 2476 to 2500 of 3,272 assets
Previous
Page 100 of 131
Next